|
Market Closed -
Nasdaq
16:00:00 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 7.790 USD | +2.91% |
|
+5.41% | -33.02% |
Company Valuation: CorMedix Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 173.2 | 174.1 | 206 | 491.5 | 916.3 | 590 | - | - |
| Change | - | 0.53% | 18.32% | 138.57% | 86.44% | -35.61% | - | - |
| Enterprise Value (EV) 1 | 107.7 | 115.3 | 130 | 439.8 | 912.4 | 480.6 | 442.7 | 590 |
| Change | - | 7.05% | 12.71% | 238.36% | 107.46% | -47.32% | -7.89% | 33.28% |
| P/E | -6.07x | -5.7x | -4.13x | -27x | 5.7x | 15.7x | 137x | 17.6x |
| PBR | 2.76x | - | 2.94x | - | 2.3x | 1.53x | 1.7x | - |
| PEG | - | 4.28x | -0.2x | 0.4x | -0x | -0.2x | -1.5x | 0x |
| Capitalization / Revenue | 907x | 2,662x | - | 11.3x | 2.94x | 1.75x | 2.04x | 1.71x |
| EV / Revenue | 564x | 1,763x | - | 10.1x | 2.93x | 1.43x | 1.53x | 1.71x |
| EV / EBITDA | - | - | - | -29.5x | 4.68x | 3.67x | 5.76x | - |
| EV / EBIT | -3.66x | -3.77x | -2.65x | -19.7x | 6.08x | 5.74x | 42.3x | 12.2x |
| EV / FCF | -4.77x | -4.69x | -3.36x | -8.67x | 5.28x | 3.55x | 6.11x | - |
| FCF Yield | -21% | -21.3% | -29.8% | -11.5% | 18.9% | 28.1% | 16.4% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.75 | -0.74 | -0.91 | -0.3 | 2.04 | 0.495 | 0.0567 | 0.4425 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.1909 | 0.0654 | - | 43.47 | 311.7 | 337.1 | 289.3 | 345.3 |
| EBITDA 1 | - | - | - | -14.89 | 195.1 | 130.9 | 76.89 | - |
| EBIT 1 | -29.44 | -30.62 | -48.96 | -22.36 | 150.1 | 83.73 | 10.48 | 48.24 |
| Net income 1 | -28.21 | -29.7 | -46.34 | -17.93 | 163.1 | 45.67 | 5.329 | 42.78 |
| Net Debt 1 | -65.47 | -58.79 | -76.03 | -51.69 | -3.905 | -109.4 | -147.3 | - |
| Reference price 2 | 4.550 | 4.220 | 3.760 | 8.100 | 11.630 | 7.790 | 7.790 | 7.790 |
| Nbr of stocks (in thousands) | 38,065 | 41,260 | 54,790 | 60,677 | 78,789 | 77,944 | - | - |
| Announcement Date | 3/29/22 | 3/30/23 | 3/12/24 | 3/25/25 | 3/5/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 15.29x | 1.43x | 3.67x | - | 590M | |
| 36.99x | 13.22x | 28x | 0.53% | 1,144B | |
| 37.96x | 6.39x | 17.99x | 2.06% | 625B | |
| 36.9x | 8.47x | 17.49x | 2.38% | 511B | |
| 21.13x | 5.1x | 12.68x | 2.57% | 377B | |
| 108.1x | 6.04x | 25.89x | 2.3% | 366B | |
| 21.5x | 5.61x | 13.79x | 2.85% | 291B | |
| 22.06x | 4.46x | 12.76x | 1.98% | 262B | |
| 27.87x | 7.15x | 12.8x | 2.3% | 237B | |
| -45.73x | 7.01x | 27.13x | 2.11% | 194B | |
| Average | 28.21x | 6.49x | 17.22x | 2.12% | 400.85B | |
| Weighted average by Cap. | 35.48x | 8.34x | 20.49x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CRMD Stock
- Valuation CorMedix Inc.
Select your edition
All financial news and data tailored to specific country editions
